IP Library Granted Patent US 11,406,630
Granted Patent B2
US 11,406,630 · App. 16/065,986 · Granted Aug 9, 2022

Nicotine pouch

Inventor: Heidi Ziegler Bruun (Vejle Ost, DK)
Assignee: NCP NextGen A/S
A61K31/465A47L9/2805A47L9/2826A47L9/2852A61K9/006A61K9/009A61K9/0056A61K47/22A61K47/38A24B15/16A47L2201/02A47L2201/04A61K47/12A61K47/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,630
App. No.
16/065,986
Granted
Aug 9, 2022
Kind
B2
Abstract

A pouch designed for administration of an active ingredient in the oral cavity is disclosed, the pouch containing a matrix composition including a combination of nicotine and a water-soluble composition.

Claims (21)

1. A pouch designed for administration of an active ingredient in the oral cavity, the pouch containing a matrix composition comprising a water-insoluble composition, and granules consisting of a combination of nicotine and a water-soluble composition, wherein the water-soluble composition comprises sugar alcohol as a water-soluble carrier for the nicotine, and wherein the water-insoluble composition comprises microcrystalline cellulose.

2. The pouch according to claim 1 , wherein said nicotine is provided as a complex between nicotine and an ion exchange resin.

3. The pouch according to claim 2 , wherein said complex between nicotine and the ion exchange resin is nicotine polacrilex resin (NPR).

4. The pouch according to claim 1 , wherein the nicotine is provided as a salt.

5. The pouch according to claim 1 , wherein the nicotine is provided as its base form.

6. The pouch according to claim 1 , wherein the water-soluble composition is a powder composition.

7. The pouch according to claim 1 , wherein the matrix composition comprises a pH controlling agent.

8. The pouch according to claim 7 , wherein the pH controlling agent is a buffering agent.

9. The pouch according to claim 7 , wherein the pH controlling agent is a basic pH controlling agent.

10. The pouch according to claim 1 , wherein the matrix composition comprises a release controlling composition.

11. The pouch according to claim 10 , wherein the release controlling composition is hydrophobic.

12. The pouch according to claim 10 , wherein said release controlling composition comprises one or more metallic stearates.

13. The pouch according to claim 10 , wherein the matrix composition comprises said release controlling composition in an amount of between 1 and 20 percent by weight of said matrix composition.

14. The pouch according to claim 10 , wherein said matrix composition comprises a first portion and a second portion, wherein said first and second portions have different contents of said release controlling composition.

15. The pouch according to claim 14 , wherein both of said first and second portions comprises nicotine.

16. The pouch according to claim 15 , wherein the pouch comprises a water-permeable membrane.

17. The pouch according to claim 15 , wherein said matrix composition comprises nicotine in an amount of 0.1 to 30 percent by weight of said matrix composition.

18. The pouch according to claim 15 , wherein the pouch comprises a humectant.

19. The pouch according to claim 15 , wherein the pouch is free of tobacco.

20. A pouch designed for administration of an active ingredient in the oral cavity, the pouch containing a matrix composition comprising a water-insoluble composition, and granules consisting of a combination of nicotine and a water-soluble composition, wherein the water-soluble composition comprises sugar alcohol as a water-soluble carrier for the nicotine, wherein the nicotine is not provided as a nicotine salt, and wherein the water-insoluble composition comprises microcrystalline cellulose.

21. The pouch according to claim 18 , wherein the humectant is selected from the group consisting of sugar alcohols, alginate, cellulose, microcrystalline cellulose, pectin, xanthan gum, and combinations thereof.

Assignments (3)
CONFIRMATION OF ASSIGNMENT Recorded Oct 10, 2022
From: NCP NEXTGEN A/S
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 061632/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2020
From: FERTIN PHARMA A/S
To: NCP NEXTGEN A/S
Reel/Frame 053641/0732 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2018
From: BRUUN, HEIDI ZIEGLER
To: FERTIN PHARMA A/S
Reel/Frame 047278/0244 →
Priority Claims (1)
WO PCT/DK2017/050211 · Jun 23, 2017 · international
Continuity (1)
Related Publication 20190255035A1 · Aug 22, 2019